Breckenridge Eyes First Kyprolis Generic With FDA Approval
US Firm Received ANDA Approval With Partner Natco
Towa’s US-based Breckenridge is aiming for exclusivity with its generic version of Amgen’s Kyprolis – developed with partner Natco Pharma – after obtaining one of the first approvals for several strengths of the treatment for relapsed or refractory multiple myeloma.
